首页> 美国卫生研究院文献>Pharmaceuticals >Electroanalysis Applied to Compatibility and Stability Assays of Drugs: Carvedilol Study Case
【2h】

Electroanalysis Applied to Compatibility and Stability Assays of Drugs: Carvedilol Study Case

机译:应用于药物的相容性和稳定性测定的电分析:Carvedilol研究案例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Carvedilol (CRV) is a non-selective blocker of α and β adrenergic receptors, which has been extensively used for the treatment of hypertension and congestive heart failure. Owing to its poor biopharmaceutical properties, CRV has been incorporated into different types of drug delivery systems and this necessitates the importance of investigating their compatibility and stability. In this sense, we have investigated the applicability of several electroanalytical tools to assess CRV compatibility with lipid excipients. Voltammetric and electrochemical impedance spectroscopy techniques were used to evaluate the redox behavior of CRV and lipid excipients. Results showed that Plurol isostearic, liquid excipient, and stearic acid presented the greatest anode peak potential variation, and these were considered suitable excipients for CRV formulation. CRV showed the highest stability at room temperature and at 50 °C when mixed with stearic acid (7% w/w). The results also provided evidence that electrochemical methods might be feasible to complement standard stability/compatibility studies related to redox reactions.
机译:卡维地洛(CRV)是α和β肾上腺素能受体的非选择性阻断剂,其已广泛用于治疗高血压和充血性心力衰竭。由于其生物药物特性差,CRV已纳入不同类型的药物递送系统,这需要调查其兼容性和稳定性的重要性。从这个意义上讲,我们已经研究了多种电解化工具的适用性评估CRV与脂质赋形剂的相容性。伏安和电化学阻抗谱技术用于评估CRV和脂质赋形剂的氧化还原行为。结果表明,Plurol异甾醇,液体赋形剂和硬脂酸呈现最大的阳极峰值电位变化,并且认为这些赋形剂是CRV制剂的合适赋形剂。 CRV在室温下稳定性最高,50℃与硬脂酸混合(7%w / w)。结果还提供了证据,即电化学方法可能是可行的补充标准稳定性/与氧化还原反应相关的兼容性研究。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号